{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:42:59Z","timestamp":1782783779529,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neuropharm.2025.110647","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:45:00Z","timestamp":1755845100000},"page":"110647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Reduced activation of pain-related brain regions with lysophosphatidic acid receptor subtype-1 antagonist PIPE-791 in a nonhuman primate model of chronic peripheral neuropathy"],"prefix":"10.1016","volume":"280","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7372-979X","authenticated-orcid":false,"given":"Aldric","family":"Hama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Baccei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1749-5622","authenticated-orcid":false,"given":"Austin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2978-5855","authenticated-orcid":false,"given":"Michael","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Stebbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Itani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6744-4701","authenticated-orcid":false,"given":"Takahiro","family":"Natsume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroryuki","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Lorrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110647_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12974-018-1378-z","article-title":"Sequential alteration of microglia and astrocytes in the rat thalamus following spinal nerve ligation","volume":"15","author":"Blaszczyk","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2025.110647_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1152\/jn.1996.76.1.571","article-title":"Comparison of human cerebral activation pattern during cutaneous warmth, heat pain, and deep cold pain","volume":"76","author":"Casey","year":"1996","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2025.110647_bib3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/j.pain.0000000000000788","article-title":"Brain activity for tactile allodynia: a longitudinal awake rat functional magnetic resonance imaging study tracking emergence of neuropathic pain","volume":"158","author":"Chang","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2025.110647_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.815945","article-title":"Modulation of neuropathic pain by glial regulation in the Insular cortex of rats","volume":"15","author":"Choi","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110647_bib5","first-page":"CD007076","article-title":"Pregabalin for neuropathic pain in adults","volume":"1","author":"Derry","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2025.110647_bib6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s40122-022-00445-2","article-title":"Different profiles of the triad of lysophosphatidylcholine, lysophosphatidic acid, and autotaxin in patients with neuropathic pain diseases: a preliminary observational study","volume":"11","author":"Edamura","year":"2022","journal-title":"Pain Ther."},{"key":"10.1016\/j.neuropharm.2025.110647_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/17448069211008697","article-title":"Pharmacological modulation of brain activation to non-noxious stimulation in a cynomolgus macaque model of peripheral nerve injury","volume":"17","author":"Hama","year":"2021","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2025.110647_bib8","first-page":"E615","article-title":"Intrathecal lentivirus-mediated transfer of interleukin-10 attenuates chronic constriction injury-induced neuropathic pain through modulation of spinal high-mobility group box 1 in rats","volume":"16","author":"He","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.neuropharm.2025.110647_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/molbev\/msv037","article-title":"Tree of life reveals clock-like speciation and diversification","volume":"32","author":"Hedges","year":"2015","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.neuropharm.2025.110647_bib10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12035-019-01719-1","article-title":"Pleotropic roles of autotaxin in the nervous system present opportunities for the development of novel therapeutics for neurological diseases","volume":"57","author":"Herr","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2025.110647_bib11","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101678R","article-title":"Lysophosphatidic acid receptor(1\/3) antagonist inhibits the activation of satellite glial cells and reduces acute nociceptive responses","volume":"36","author":"Hoshino","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2025.110647_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102051","article-title":"Neuron-glia crosstalk and neuropathic pain: involvement in the modulation of motor activity in the orofacial region","volume":"18","author":"Hossain","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110647_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuroimage.2014.12.024","article-title":"Behavioral, metabolic and functional brain changes in a rat model of chronic neuropathic pain: a longitudinal MRI study","volume":"107","author":"Hubbard","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2025.110647_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1745-6215-12-55","article-title":"Effect of a single dose of pregabalin on Herpes zoster pain","volume":"12","author":"Jensen-Dahm","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.neuropharm.2025.110647_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.16206","article-title":"Unraveling the role of oligodendrocytes and myelin in pain","volume":"169","author":"Kim","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110647_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207310","article-title":"Lysophosphatidic acid is associated with neuropathic pain intensity in humans: an exploratory study","volume":"13","author":"Kuwajima","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110647_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065736","article-title":"The role of the Insular cortex in pain","volume":"24","author":"Labrakakis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110647_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112745","article-title":"Synaptic plasticity in the pain-related cingulate and Insular cortex","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuropharm.2025.110647_bib19","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1021\/jasms.0c00429","article-title":"Serum lysophosphatidic acid measurement by liquid chromatography-mass spectrometry in COPD patients","volume":"32","author":"Li","year":"2021","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.neuropharm.2025.110647_bib20","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/j.pain.0000000000003342","article-title":"\"Neuroinflammation\": does it have a role in chronic pain? Evidence from human imaging","volume":"165","author":"Loggia","year":"2024","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2025.110647_bib21","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1523\/JNEUROSCI.1897-22.2023","article-title":"Contralateral afferent input to lumbar lamina I neurons as a neural substrate for mirror-image pain","volume":"43","author":"Luz","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110647_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1744-8069-9-29","article-title":"An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model","volume":"9","author":"Ma","year":"2013","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2025.110647_bib23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1471-4159.2010.06955.x","article-title":"Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain","volume":"115","author":"Ma","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110647_bib24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1142\/S0192415X06004296","article-title":"Positron emission tomography analysis of the analgesic effects of acupuncture in rhesus monkeys","volume":"34","author":"Maenaka","year":"2006","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.neuropharm.2025.110647_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2147\/JPR.S60433","article-title":"Brain imaging of pain: state of the art","volume":"9","author":"Morton","year":"2016","journal-title":"J. Pain Res."},{"key":"10.1016\/j.neuropharm.2025.110647_bib26","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1471-4159.2006.03824.x","article-title":"Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction","volume":"97","author":"Narita","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110647_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61369-9","article-title":"Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis","volume":"14","author":"Poon","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110647_bib28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/glia.23585","article-title":"Lysophosphatidic acid activates satellite glia cells and schwann cells","volume":"67","author":"Robering","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2025.110647_bib29","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1523\/JNEUROSCI.4703-14.2015","article-title":"Activation of lysophosphatidic acid receptor type 1 contributes to pathophysiology of spinal cord injury","volume":"35","author":"Santos-Nogueira","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110647_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1017\/cjn.2023.10","article-title":"The known biology of neuropathic pain and its relevance to pain management","volume":"51","author":"Smith","year":"2024","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110647_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neulet.2017.10.023","article-title":"Lysophosphatidic acid propagates post-injury schwann cell dedifferentiation through LPA(1) signaling","volume":"662","author":"Szepanowski","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2025.110647_bib32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/jnc.14001","article-title":"Neuronal and microglial mechanisms for neuropathic pain in the spinal dorsal horn and anterior cingulate cortex","volume":"141","author":"Tsuda","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2025.110647_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2217\/pmt-2019-0036","article-title":"LPA receptor signaling as a therapeutic target for radical treatment of neuropathic pain and fibromyalgia","volume":"10","author":"Ueda","year":"2020","journal-title":"Pain Manag."},{"key":"10.1016\/j.neuropharm.2025.110647_bib34","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1097\/j.pain.0000000000001316","article-title":"Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain","volume":"159","author":"Ueda","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2025.110647_bib35","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuropharm.2016.04.002","article-title":"Lysophosphatidic acid receptors (LPARs): potential targets for the treatment of neuropathic pain","volume":"113","author":"Velasco","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110647_bib36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bja.2017.11.064","article-title":"Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging","volume":"120","author":"Wanigasekera","year":"2018","journal-title":"Br. J. Anesth."},{"key":"10.1016\/j.neuropharm.2025.110647_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/cne.901880404","article-title":"The cells of origin of the primate spinothalamic tract","volume":"188","author":"Willis","year":"1979","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110647_bib38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.neuroscience.2009.03.016","article-title":"Early blockade of injured primary sensory afferents reduces glial cell activation in two rat neuropathic pain models","volume":"160","author":"Xie","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2025.110647_bib39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00702-014-1289-9","article-title":"Lysophosphatidic acid induces anxiety-like behavior via its receptors in mice","volume":"122","author":"Yamada","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.neuropharm.2025.110647_bib40","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1213\/ANE.0000000000000020","article-title":"Intrathecal ultra-low dose naloxone enhances the antihyperalgesic effects of morphine and attenuates tumor necrosis factor-alpha and tumor necrosis factor-alpha receptor 1 expression in the dorsal horn of rats with partial sciatic nerve transection","volume":"117","author":"Yang","year":"2013","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2025.110647_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1744-8069-4-15","article-title":"Selective activation of microglia in spinal cord but not higher cortical regions following nerve injury in adult mouse","volume":"4","author":"Zhang","year":"2008","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2025.110647_bib42","article-title":"Advances and challenges in neuroimaging-based pain biomarkers","volume":"5","author":"Zhang","year":"2024","journal-title":"Cell Rep. Med."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:21:08Z","timestamp":1768512068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":42,"alternative-id":["S0028390825003557"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110647","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced activation of pain-related brain regions with lysophosphatidic acid receptor subtype-1 antagonist PIPE-791 in a nonhuman primate model of chronic peripheral neuropathy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110647"}}